Company: SMNR
Filing Date: 2025-08-12
Form Type: S-4/A
Source: 0001193125-25-178821
Chunk: 769

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: S-4/A
Chunk 769
---
 other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |

| Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |

The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2024 and December 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

| Assets:                           |     | As ofDecember 31,2024 |           |     | QuotedPrices inActiveMarkets(Level 1) |   |     | SignificantOtherObservableInputs(Level 2) |           |     | SignificantOtherUnobservable 
 Inputs(Level 3)              |   |
|:----------------------------------|:----|:----------------------|----------:|:----|:--------------------------------------|:--|:----|:------------------------------------------|----------:|:----|:-----------------------------|:--|
| Investments held in Trust Account |     | $                     | 9,021,005 |     | $                                     | — |     | $                                         | 9,021,005 |     |                              | — |

| Assets:                           |     | As ofDecember 31,2023 |            |     | QuotedPrices inActiveMarkets(Level 1) |            |     | SignificantOtherObservableInputs(Level 2) |   |     | SignificantOtherUnobservableInputs(Level 3) |   |
|:----------------------------------|:----|:----------------------|-----------:|:----|:--------------------------------------|-----------:|:----|:------------------------------------------|:--|:----|:--------------------------------------------|:--|
| Investments held in Trust Account |     | $                     | 50,477,963 |     | $                                     | 50,477,963 |     | $                                         | — |     |                                             | — |

NOTE 9 – SEGMENT INFORMATION ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance